|
FDA Reviews Safety Of HIV Drugs On Heart
Attack Concerns
by The Canadian Press
Posted: March 28, 2008 - 11:00 am ET
(Washington) The Food and Drug Administration
says recent data show
patients taking HIV drugs from
GlaxoSmithKline and Bristol-Myers Squibb may have increased risk of heart
attack.
FDA said data pooled from a 33,000-patient study of
HIV
patients showed those taking Glaxo's Ziagen and Bristol-Myers' Videx had a
greater chance of heart attack than patients on other medications.
Labeling changes could be needed for the drugs, FDA said, though it stressed
it is still working with incomplete data. The agency does not have information
on heart attack risks of two other drugs in the class of virus-fighting
medications.
In an announcement posted to its website, FDA said it would make
recommendations on the drugs after it completes its review.
Until then, doctors should weigh the risks and benefits of the drugs for
patients, the agency said.
Glaxo and Bristol reviewed their clinical trial data on the drugs and both
said they found no increased risk of heart attack.
Company representatives did not immediately
return phone calls.
©365Gay.com 2008
|
Entertainment
